Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,388 | 172 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $473.26 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $403.60 | 16 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $403.09 | 4 | $0 (2024) |
| ITI, Inc. | $291.91 | 17 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $267.05 | 11 | $0 (2024) |
| Novo Nordisk Inc | $256.22 | 17 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $242.55 | 7 | $0 (2024) |
| Lilly USA, LLC | $211.68 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $142.63 | 9 | $0 (2024) |
| Lundbeck LLC | $103.94 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,427 | 55 | Supernus Pharmaceuticals, Inc. ($342.68) |
| 2023 | $1,739 | 104 | ABBVIE INC. ($226.39) |
| 2022 | $222.24 | 13 | ITI, Inc. ($98.18) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Obesity | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: VACCINE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $117.43 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.66 | General |
About Teandrea Mcdaniel, NP
Teandrea Mcdaniel, NP is a Adult Health healthcare provider based in Muskegon Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2022. The National Provider Identifier (NPI) number assigned to this provider is 1598494734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Teandrea Mcdaniel, NP has received a total of $3,388 in payments from pharmaceutical and medical device companies, with $1,427 received in 2024. These payments were reported across 172 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,388).
Practice Information
- Specialty Adult Health
- Location Muskegon Heights, MI
- Active Since 06/05/2022
- Last Updated 06/05/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598494734
Products in Payments
- CAPLYTA (Drug) $534.46
- VRAYLAR (Drug) $393.32
- Qelbree (Drug) $342.68
- AREXVY (Drug) $269.10
- Austedo XR (Drug) $235.34
- REXULTI (Drug) $173.57
- TRELEGY ELLIPTA (Drug) $134.50
- MOUNJARO (Drug) $104.75
- Cologuard Collection Kit (Device) $102.25
- Kerendia (Drug) $96.81
- Ozempic (Drug) $82.06
- Rybelsus (Drug) $79.55
- Lucemyra (Drug) $75.56
- QELBREE (Drug) $60.41
- TRULICITY (Drug) $52.47
- INGREZZA (Drug) $45.03
- ABILIFY MAINTENA (Drug) $39.92
- UBRELVY (Drug) $39.36
- ABILIFY ASIMTUFII (Drug) $33.08
- AUSTEDO (Drug) $26.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.